Ashley Cimino-Mathews
Johns Hopkins University
H-index: 47
North America-United States
Top articles of Ashley Cimino-Mathews
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Radiologic-pathologic correlation of nonmass enhancement contiguous with malignant index breast cancer masses at preoperative breast MRI | Radiology: Imaging Cancer | Derek L Nguyen Mira Lotfalla Ashley Cimino-Mathews Mehran Habibi Emily B Ambinder | 2024/2/2 |
Association between pathologic response and survival after neoadjuvant therapy in lung cancer | Nature medicine | Julie Stein Deutsch Ashley Cimino-Mathews Elizabeth Thompson Mariano Provencio Patrick M Forde | 2024/1 |
Abstract PO1-01-09: Neoadjuvant endocrine therapy and avelumab with or without palbociclib in stage II/III endocrine receptor-positive breast cancer: the ImmunoADAPT trial | Cancer Research | Phaedon Zavras Ruizhe Chen Hanfei Qi Mary Kate Jones Ann Folmer | 2024/5/2 |
Epigenetic modulation decreases myeloid suppression to improve response to immune checkpoint inhibition in breast cancer | Cancer Research | Aaron G Baugh Edgar Gonzalez Jesse Kreger Yingtong Liu Batul Al-Zubeidy | 2024/3/22 |
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial | Nature Cancer | Evanthia T Roussos Torres Won J Ho Ludmila Danilova Joseph A Tandurella James Leatherman | 2024/2/14 |
333P Evaluation of a composite PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant HER2-directed therapy in early breast cancer (TBCRC026) | Annals of Oncology | MA Hennessy A Cimino-Mathews J Carter J Kachergus Y Ma | 2023/10/1 |
Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer | bioRxiv | Haoyang Mi Ravi Varadhan Ashley M Cimino-Mathews Leisha A Emens Cesar A Santa-Maria | 2023 |
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer | Science translational medicine | Nitasha Gupta Tzu-Ting Huang Jayakumar R Nair Daniel An Grant Zurcher | 2023/6/21 |
Multimodal genome-wide survey of progressing and non-progressing DCIS | Cancer Research | Marija Debeljak Soonweng Cho Bradley Downs Michael Considine Brittany Avin-McKelvey | 2023/4/4 |
222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816 | Julie Stein Deutsch Ashley Cimino-Mathews Elizabeth Thompson Mariano Provencio Patrick M Forde | 2023/11/1 | |
Entinostat’s modulation of myeloid derived suppressor cells through the STAT3-NFκB-AP-1 axis decreases suppressive signaling | Cancer Research | Aaron G Baugh Edgar Gonzalez Valerie H Narumi Sofi Castanon Jesse Kreger | 2023/4/4 |
1511 Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant IO trials (PATHdata): Interim analysis of a multi-institutional … | Julie S Deutsch Tricia Cottrell Krista Chen Carlos E de Andrea Pierre-Olivier Fiset | 2023/11/1 | |
Abstract P2-20-14: Relationship of HIF-1α and tumor infiltrating lymphocytes in patients with HER2-negative early-stage breast cancer treated with neoadjuvant chemotherapy | Cancer Research | Harsh Oza Victoria Grabinski Hector Ibanez Ines Godet Daniele Gilkes | 2023/3/1 |
Correlation of SUV on early interim PET with recurrence-free survival and overall survival in primary operable HER2-positive breast cancer (the TBCRC026 trial) | Journal of Nuclear Medicine | Maeve A Hennessy Jeffrey P Leal Chiung-Yu Huang Lilja B Solnes Rita Denbow | 2023/11/1 |
A new landscape of testing and therapeutics in metastatic breast cancer | Geetha Jagannathan Marissa J White Rena R Xian Leisha A Emens Ashley Cimino-Mathews | 2022/3/1 | |
MYB RNA in situ hybridization is a useful diagnostic tool to distinguish breast adenoid cystic carcinoma from other triple-negative breast carcinomas | The American Journal of Surgical Pathology | Monica R Butcher Marissa J White Lisa M Rooper Pedram Argani Ashley Cimino-Mathews | 2022/7/1 |
Radiologic-Pathologic Correlation of Non-Mass Enhancement Associated with Malignant Breast Cancer Masses | Derek Le Nguyen Mira Lotfalla Ashley Cimino-Mathews Mehran Habibi Emily Bayle Ambinder | 2022/9/8 | |
Developing asymmetries without sonographic correlate at digital breast tomosynthesis | Radiology | Angela Liang Ezra Baraban Kelly S Myers Lisa A Mullen Babita Panigrahi | 2022/3 |
Quiescent cancer cells: Therapeutic targets to overcome immunotherapy resistance? | Med | Leisha A Emens Ashley Cimino-Mathews | 2022/6/10 |
LBA50 analysis of pathological features and efficacy outcomes with neoadjuvant nivolumab (N) plus platinum-doublet chemotherapy (C) for resectable non-small cell lung cancer … | Annals of Oncology | JS Deutsch A Cimino-Mathews ED Thompson D Wang RA Anders | 2022/9/1 |
